Renal Osteopontin Expression in Experimental Urolithiasis
Authors:
- Paramjit S. ChandhokePCParamjit S. Chandhoke
- Jie FanJFJie Fan
- Scott LuciaSLScott Lucia
- 1 April 1998
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 12 (2) , 171-176
Abstract
Although osteopontin (Opn) is a strong inhibitor of calcium oxalate crystallization in vitro, its role in stone formation in vivo is unknown. We investigated the renal expression of Opn in normal, ethylene glycol (EG), and EG + ammonium chloride-treated rats. Male Sprague-Dawley rats were divided into three groups. Group 1 (N = 5) was the control. Animals in Group 2 (N = 6) received 4 weeks of treatment with 0.75% EG, and Group 3 animals (N = 6) were given 1 week of treatment with 0.75% EG and 1.0% NH4Cl. The kidneys were then examined for crystal deposition and Opn localization. In normal rats, staining for Opn was evident in the proximal tubules (PT; S3 > S2 > S1), distal tubules (DT), and the thick ascending limbs of Henle (TAL) and a few collecting ducts (CD). All rats in Group 3 had significant crystal deposition throughout their kidneys. In Group 2 rats, Opn staining increased in all segments of the PT, DT, and TAL. Staining in these tubular segments was even greater in Group 3 rats, including the CD and the papillary surface epithelium. In addition, Opn was present within all crystal deposits. Renal Opn expression in experimental urolithiasis becomes stronger and more diffuse as the severity of the lithiasis-inducing treatment increases. These results are consistent with the hypothesis that renal epithelial cells produce larger amounts of osteopontin to combat the development of kidney stones.Keywords
This publication has 12 references indexed in Scilit:
- Localization of Tamm-Horsfall Protein and Osteopontin in a Rat Nephrolithiasis ModelNephron, 1996
- Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculiJournal of Bone and Mineral Research, 1995
- Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidneyKidney International, 1995
- Structure and expression of the mRNA encoding urinary stone protein (osteopontin)Journal of Biological Chemistry, 1993
- Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces.Molecular Biology of the Cell, 1992
- The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontinJournal of Bone and Mineral Research, 1992
- Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.Proceedings of the National Academy of Sciences, 1992
- The Nature and Significance of OsteopontinConnective Tissue Research, 1989
- Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridizationJournal of Cell Biology, 1988
- 44-kDal bone phosphoprotein (osteopontin) antigenicity at ectopic sites in newborn rats: kidney and nervous tissuesCell and tissue research, 1988